James Black Quotes

Analytical pharmacology has got an important and exciting future.

Pharmacology is benefited by the prepared mind. You need to know what you are looking for.

Drug discovery is terribly expensive, just to find out how one drug could or could not work and all its side effects.

If we can actually decrease the failure rate from nine out of 10 drugs failing in clinical trials and instead have seven out of 10 instead failing, that is a major victory for drug discovery and for people having better therapy.

To start with, pharma was an industry based on innovation, drug discovery.

There's always going to be the need for new medications, better medications.

Now, what tends to happen is that the stories get hyped. And the medicines are not quite as revolutionary and as dramatic as they seem to be. But, certainly, various phases of this problem are being attacked by the pharmaceutical companies.

Perhaps the most useful lesson which has come out of the work on penicillin has been the demonstration that success in this field depends on the development and coordinated use of technical methods.

The United States has an active pharmaceutical industry that has brought huge benefits to the U.S. public. Most Americans, who benefit from these advances, have little understanding of how difficult it is to create an important new medical therapy and make it available to improve public health.

Even then, Vanderbilt was the premiere place for clinical pharmacology.

Bayer Pharmaceutical Products: Aspirin, Heroin, Lycetrol: Send for Samples and Literature

There is probably a promising drug candidate that has already been discovered for the treatment of Down syndrome that is sitting on the shelf of some drug company.

Once an effective drug is approved to treat a deadly condition, introducing a second drug to treat the same disease can be hard. It's tough to recruit patients with a debilitating disease for a clinical trial when a proven medicine is already available.

The problem we are trying to solve is that of drugs that would have never seen the light of day for reasons that have nothing to do with the inherent properties of drug candidates themselves and more to do with bureaucratic institutions within which they often sit.

In general, drug companies are reasonably good at developing new treatments, and there's also a lot of good in the industry.

I keep encouraging the pharmaceutical companies to put more money into R&D.

If you sit in a position where decisions that you take would have a serious effect on people, you can't ignore a lot of experience around the world which says this drug has these negative effects.

Originally, in the early eighties, the drug hypothesis was among the first which occurred to scientists.

I want to make a drug. I want the science to be more than imaginary, where I think, 'We're learning these fundamental principles, blah, blah, blah, blah, blah.' I think we are doing that, but I want to do something really practical. I want to actually, in my lifetime, help people.

I really was inspired by the possibility of more directly being involved in the development of drugs myself.

In contrast to how tech firms want to disrupt and break things - developing drugs must be incremental and step-by-step. This is the kind of work that involves people putting their lives on the line every day with clinical trials.

My choice of learning pharmacy was driven by my interests, curiosity, and a desire to seek new medicines for patients.

I've heard drug experts say they believe if penicillin were discovered today, the FDA wouldn't license it.

On the third stage is used for medicine, it is not known to the public.

I agree, the world would be a better place if doctors were less enthusiastic about adopting very new drugs.